| Price | $87.16 |
| Year Range | $73.1 – $102.8 |
| Market Cap | $109B |
| PE Ratio | 23.03 |
| Industry | Medical Devices |
What Is Medtronic’s AI Stock Analysis?
Medtronic’s AI stock analysis on AltIndex combines the company’s fundamentals, price technicals and 25+ alternative data signals — like hiring, web traffic, app downloads and online sentiment — into a single AI Score from 0 to 100 and a plain-English Buy, Hold or Sell read. Unlike a traditional analyst rating that updates a few times a year, the AI Score refreshes as new data arrives, so it tracks Medtronic’s momentum in near-real time.
Medtronic (MDT) has an AltIndex AI Score of 64/100, currently a Buy signal. The AI Score distills Medtronic's fundamentals, price technicals and 25+ alternative data signals into a single 0–100 rating, so a rising score reflects strengthening data across the board and a falling score the opposite.
Medtronic’s Full AI Analysis
Keep reading AltIndex’s full AI analysis of Medtronic — the fundamental, technical and alternative-data breakdown and the recommendation.
Sign up to read the full analysisWhat’s Driving MDT’s AI Score?
Fundamentals
Revenue for the last quarter was $9.02B. This is an increase of 0.64% compared to the quarter before it, which is a positive sign of growth. Compared to the same quarter last year, there is an increase of 8.76%, suggesting positive year-over-year growth. Net income for the last quarter was $1.14B. This represents a decrease of 16.81% compared to the quarter before it, indicating a need for concern. However, compared to the same quarter last year, there is a decrease of 11.67%, which may be a cause for concern. Ebitda for the last quarter was $2.68B. This is an increase of 13.19% compared to the quarter before it, which is a positive sign of growth. Compared to the same quarter last year, there is an increase of 11.44%, suggesting positive year-over-year growth. The current P/E ratio is 23.03. This appears to be within a normal range, neither particularly high nor low. In the last couple of months, there's been a couple of company insiders selling their stock, a potentially bearish signal.
See Medtronic’s earnings and insider transactions.
Technicals
Today's stock price is $87.16. This is an increase of 6.28% compared to a month ago, indicating a positive short-term trend. However, compared to a year ago, there is a decrease of 3.12%, which could be a cause for long-term concern. The trend is bullish. The current SMA10 is $86.14, which is higher than the previous SMA10 of $86.11. This indicates a potential upward trend in price movement. The RSI is 49.4, indicating a neutral condition.
See the full technical analysis and price prediction.
Alternative data
Medtronic has an estimated 1,102 open positions and this number has been stable over the last couple of months indicating a company in a stable position. The business outlook among employees at Medtronic is neutral. Medtronic has an estimate of 2.3M visitors to their webpage. The number of visitors is down by -7% in the last couple of months, a worrisome trend as this can indicate a loss in customers. Medtronic has an estimate of 33 users downloading their mobile apps every day. The number of downloads is down by -75% in the last couple of months, a worrisome trend as this can indicate a loss in customers.
Explore Medtronic’s job postings, web traffic and app downloads.
Sentiment & social
Medtronic has 55,000 followers on their Instagram page. The number of followers is up by 15% in the last couple of months, indicating an increased interest in the company. Medtronic has 85,000 followers on their Twitter page. The number of followers is down by -0% in the last couple of months, indicating a loss in interest in the company.
Track Medtronic’s market sentiment.
Frequently Asked Questions: Medtronic AI Stock Analysis
Medtronic's AltIndex AI Score is 64/100, currently a Buy signal. The AI Score blends fundamentals, technicals and 25+ alternative data signals into a single rating from 0 to 100.
AltIndex's AI Score model rates Medtronic a Buy (64/100). This is a data-driven signal, not investment advice — review the breakdown above and combine it with your own research.
The AI Score is generated from fundamental data (earnings, valuation), technical indicators (price trend and momentum), and alternative data signals such as hiring, web traffic, app downloads and sentiment. AltIndex weighs these into a single 0-100 score; the exact weighting is proprietary.
AltIndex generates a complete written AI analysis of Medtronic — company overview, fundamentals, technicals and alternative data, with a recommendation. See the MDT AI Score or sign up to read the full thesis.
